Patents by Inventor Lauri Diehl
Lauri Diehl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220357343Abstract: Methods of assessing or monitoring the effect, efficacy, responsiveness to treatment, and/or determining a dose or dosing regimen of therapeutic agents, such as integrin beta7 antagonists, for the treatment of gastrointestinal inflammatory disorders are provided. In certain aspects, methods of using integrin beta7 subunit-containing receptor occupancy by the integrin beta7 antagonist on colonic lymphocytes as an indicator (“biomarker”) of the effect, efficacy, or responsiveness to treatment, and/or as a means to determine dosing or dosing regimens of therapeutic agents such as beta7 integrin antagonists for the treatment of gastrointestinal inflammatory disorders are provided. In certain aspects, methods of assessing the effect, efficacy, or responsiveness to beta7 integrin antagonist treatment by measuring gene expression levels of one or more integrin receptor ligands, lymphocyte genes, cytokine genes, or the number of alphaE-positive cells in intestinal crypt epithelium are provided.Type: ApplicationFiled: December 15, 2021Publication date: November 10, 2022Applicant: GENENTECH, INC.Inventors: Lauri Diehl, Mary Keir, Meina Tao Tang, Xiaohui Wei, Marna B. Williams
-
Publication number: 20200025775Abstract: Methods of assessing or monitoring the effect, efficacy, responsiveness to treatment, and/or determining a dose or dosing regimen of therapeutic agents, such as integrin beta7 antagonists, for the treatment of gastrointestinal inflammatory disorders are provided. In certain aspects, methods of using integrin beta7 subunit-containing receptor occupancy by the integrin beta7 antagonist on colonic lymphocytes as an indicator (“biomarker”) of the effect, efficacy, or responsiveness to treatment, and/or as a means to determine dosing or dosing regimens of therapeutic agents such as beta7 integrin antagonists for the treatment of gastrointestinal inflammatory disorders are provided. In certain aspects, methods of assessing the effect, efficacy, or responsiveness to beta7 integrin antagonist treatment by measuring gene expression levels of one or more integrin receptor ligands, lymphocyte genes, cytokine genes, or the number of alphaE-positive cells in intestinal crypt epithelium are provided.Type: ApplicationFiled: February 28, 2019Publication date: January 23, 2020Applicant: GENENTECH, INC.Inventors: Lauri Diehl, Mary Keir, Meina Tao Tang, Xiaohui Wei, Marna B. Williams
-
Patent number: 9562097Abstract: This invention relates to compositions comprising anti-CD83 agonist antibodies and methods of treating autoimmune disorders (such as inflammatory bowel disease) with anti-CD83 agonist antibodies, as well as articles of manufacture comprising anti-CD83 agonist antibodies.Type: GrantFiled: June 29, 2012Date of Patent: February 7, 2017Assignee: Genentech, Inc.Inventors: Lauri Diehl, Jennifer Bates, Tao Sai
-
Publication number: 20160209426Abstract: Methods of assessing or monitoring the effect, efficacy, responsiveness to treatment, and/or determining a dose or dosing regimen of therapeutic agents, such as integrin beta7 antagonists, for the treatment of gastrointestinal inflammatory disorders are provided. In certain aspects, methods of using integrin beta7 subunit-containing receptor occupancy by the integrin beta7 antagonist on colonic lymphocytes as an indicator (“biomarker”) of the effect, efficacy, or responsiveness to treatment, and/or as a means to determine dosing or dosing regimens of therapeutic agents such as beta7 integrin antagonists for the treatment of gastrointestinal inflammatory disorders are provided. In certain aspects, methods of assessing the effect, efficacy, or responsiveness to beta7 integrin antagonist treatment by measuring gene expression levels of one or more integrin receptor ligands, lymphocyte genes, cytokine genes, or the number of alphaE-positive cells in intestinal crypt epithelium are provided.Type: ApplicationFiled: September 18, 2015Publication date: July 21, 2016Applicant: GENENTECH, INC.Inventors: Lauri Diehl, Mary Keir, Meina Tao Tang, Xiaohui Wei, Marna B. Williams
-
Publication number: 20140286950Abstract: This invention relates to compositions comprising anti-CD83 agonist antibodies and methods of treating autoimmune disorders (such as inflammatory bowel disease) with anti-CD83 agonist antibodies, as well as articles of manufacture comprising anti-CD83 agonist antibodies.Type: ApplicationFiled: June 29, 2012Publication date: September 25, 2014Applicant: Genentech, Inc.Inventors: Lauri Diehl, Jennifer Bates, Tao Sai
-
Publication number: 20140179620Abstract: The present invention relates to methods of gene expression profiling for inflammatory bowel disease pathogenesis, in which the differential expression in a test sample from a mammalian subject of one or more IBD markers relative to a control is determined, wherein the differential expression in the test sample is indicative of an IBD in the mammalian subject from which the test sample was obtained.Type: ApplicationFiled: August 12, 2013Publication date: June 26, 2014Applicant: GENENTECH, INC.Inventors: Alexander R. Abbas, Hilary Clark, Lauri Diehl, Charles Lees, Colin L. Noble, Jack Satsangi
-
Publication number: 20140154275Abstract: The present invention relates to methods of gene expression profiling for inflammatory bowel disease pathogenesis, in which the differential expression in a test sample from a mammalian subject of one or more IBD markers relative to a control is determined, wherein the differential expression in the test sample is indicative of an IBD in the mammalian subject from which the test sample was obtained.Type: ApplicationFiled: September 6, 2013Publication date: June 5, 2014Applicant: GENENTECH, INC.Inventors: Alexander R. Abbas, Hilary Clark, Lauri Diehl, Charles Lees, Colin L. Noble, Jack Satsangi
-
Publication number: 20130261025Abstract: The present invention provides for a method of detecting the presence of inflammatory bowel disease in gastrointestinal tissues or cells of a mammal by detecting increased expression of LY6 genes in the tissues or cells of the mammal relative to a control.Type: ApplicationFiled: August 2, 2012Publication date: October 3, 2013Inventors: Lauri Diehl, Kenneth Flanagan, Lian Mo
-
Patent number: 8257923Abstract: The present invention provides for a method of detecting the presence of inflammatory bowel disease in gastrointestinal tissues or cells of a mammal by detecting increased expression of LY6 genes in the tissues or cells of the mammal relative to a control.Type: GrantFiled: January 4, 2011Date of Patent: September 4, 2012Assignee: Genetech, Inc.Inventors: Lauri Diehl, Kenneth Flanagan, Lian Mo
-
Publication number: 20110177504Abstract: The present invention provides for a method of detecting the presence of inflammatory bowel disease in gastrointestinal tissues or cells of a mammal by detecting increased expression of LY6 genes in the tissues or cells of the mammal relative to a control.Type: ApplicationFiled: January 4, 2011Publication date: July 21, 2011Inventors: Lauri Diehl, Kenneth Flanagan, Lian Mo
-
Publication number: 20110033486Abstract: The present invention relates to methods of gene expression profiling for inflammatory bowel disease pathogenesis, in which the differential expression in a test sample from a mammalian subject of one or more IBD markers relative to a control is determined, wherein the differential expression in the test sample is indicative of an IBD in the mammalian subject from which the test sample was obtained.Type: ApplicationFiled: July 19, 2010Publication date: February 10, 2011Inventors: Alexander R. ABBAS, Hilary Clark, Lauri Diehl, Charles Lees, Colin L. Noble, Jack Satsangi
-
Patent number: 7875431Abstract: The present invention provides for a method of detecting the presence of inflammatory bowel disease in gastrointestinal tissues or cells of a mammal by detecting increased expression of LY6 genes in the tissues or cells of the mammal relative to a control.Type: GrantFiled: February 22, 2008Date of Patent: January 25, 2011Assignee: Genentech, Inc.Inventors: Lauri Diehl, Kenneth Flanagan, Lian Mo
-
Publication number: 20100004213Abstract: The present invention relates to methods of gene expression profiling for inflammatory bowel disease pathogenesis, in which the differential expression in a test sample from a mammalian subject of one or more IBD markers relative to a control is determined, wherein the differential expression in the lest sample is indicative of an IBD in the mammalian subject from which the lest sample was obtained.Type: ApplicationFiled: November 26, 2008Publication date: January 7, 2010Inventors: Alexander R. Abbas, Hilary Clark, Lauri Diehl, Charles Lees, Colin L. Noble, Jack Satsangi
-
Publication number: 20090186034Abstract: The present invention relates to methods of gene expression profiling for inflammatory bowel disease pathogenesis, in which the differential expression in a test sample from a mammalian subject of one or more IBD markers relative to a control is determined, wherein the differential expression in the test sample is indicative of an IBD in the mammalian subject from which the test sample was obtained.Type: ApplicationFiled: December 19, 2007Publication date: July 23, 2009Applicant: Genetech, Inc.Inventors: Alexander Abbas, Hilary Clark, Lauri Diehl
-
Publication number: 20090155788Abstract: The present invention provides for a method of detecting the presence of inflammatory bowel disease in gastrointestinal tissues or cells of a mammal by detecting decreased expression of Indian Hedgehog (Ihh) and/or increased expression of Defensin A5 (DefA5) and/or Defensin A6 (DefA6) in the tissues or cells of the mammal relative to a control.Type: ApplicationFiled: May 22, 2008Publication date: June 18, 2009Inventors: Alexander R. Abbas, Lauri Diehl, Charles Lees, Colin L. Noble, Jack Satsangi
-
Publication number: 20090111102Abstract: The present invention provides for a method of detecting the presence of inflammatory bowel disease in gastrointestinal tissues or cells of a mammal by detecting increased expression of LY6 genes in the tissues or cells of the mammal relative to a control.Type: ApplicationFiled: February 22, 2008Publication date: April 30, 2009Applicant: Genentech, Inc.Inventors: Lauri Diehl, Kenneth Flanagan, Lian Mo
-
Publication number: 20070003545Abstract: The present invention is directed to novel polypeptides having structural homology to IL-8 and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided herein are methods for treatment and diagnosis of inflammatory diseases.Type: ApplicationFiled: July 8, 2004Publication date: January 4, 2007Inventors: Dan Eaton, Maria Pisabarro, Kerstin Schmidt, Richard Vandlen, Nancy Chiang, Lauri Diehl
-
Publication number: 20060183169Abstract: The present invention is directed to novel polypeptides having structural homology to IL-8 and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided herein are methods for treatment and diagnosis of inflammatory diseases.Type: ApplicationFiled: April 21, 2006Publication date: August 17, 2006Inventors: Dan Eaton, Maria Pisabarro, Kerstin Schmidt, Richard Vandlen, Nancy Chiang, Lauri Diehl
-
Publication number: 20050100544Abstract: The present invention is directed to novel polypeptides having structural homology to IL-8 and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided herein are methods for treatment and diagnosis of inflammatory diseases.Type: ApplicationFiled: July 8, 2004Publication date: May 12, 2005Inventors: Dan Eaton, Maria Pisabarro, Kerstin Schmidt, Richard Vandlen, Nancy Chiang, Lauri Diehl